论文信息 - Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis - 字舞流文

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis

J. Pope | J. Merrill | A. Kivitz | E. Olech | C. Pacheco-Tena | S. Radominski | C. Nasmyth-Miller | F. Navarro-Sarabia | J. Pei | M. Borofsky | B. Zazueta | C. Nasmyth‐Miller